If they split the company in two that is in generics with all the debt in one company and their copaxone and pipe line in another, then the second company might be of intrest at the right price...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.